Skip to content

A prospective cohort study of the clinical outcomes of net ultrafiltration intensity in patients with septic acute kidney injury in continuous renal replacement therapy

A prospective cohort study of the clinical outcomes of net ultrafiltration intensity in patients with septic acute kidney injury in continuous renal replacement therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057055
Enrollment
Unknown
Registered
2022-02-27
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic acute kidney injury

Interventions

Low intensity net ultrafiltration group:Low intensity net ultrafiltration
Middle intensity net ultrafiltration group:Middle intensity net ultrafiltration
High intensity net ultrafiltration group:High intensity net ultrafiltration

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. Evidence of sepsis(patients with infection or suspected infection, SOFA score increased by >= 2 points from baseline); 3. Evidence of AKI based on at least one of the following three criteria: (1) Creatinine increased by >=0.3 mg/dl(>=26.5umol/l) within 48 hours; (2) Creatinine rises to =1.5 times baseline within 7 days; (3) Urine output <0.5ml/kg and lasted for 6 hours; 4. The clinician judges that renal replacement therapy is required.

Exclusion criteria

Exclusion criteria: 1. Patients with end-stage renal disease receiving maintenance hemodialysis or peritoneal dialysis; 2. Had a kidney transplant within the past year; 3. Received point-of-care renal replacement therapy in another treatment unit prior to admission to the ICU; 4. The researchers judged it inappropriate to participate in the study (Expect death within 48 hours; CRRT is expected to last less than 24 hours; The patient refused active treatment); 5. Participated in other clinical trials within 30 days.

Design outcomes

Primary

MeasureTime frame
Medical history;Baseline laboratory test;Net ultrafiltration volume;Creatinine;90-day mortality;1-year mortality;RRT dependence;

Countries

China

Contacts

Public ContactJin Lin

Beijing Friendship Hospital, Capital Medical University

jin0419@hotmail.com+86 13693261242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026